View in EDS

EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective.

Saved in:
Bibliographic Details
Title: EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective.
Authors: Liu, T1 (AUTHOR), Purser, M1 (AUTHOR), Gong, C2 (AUTHOR), Elsea, D2 (AUTHOR), Niehoff, N1 (AUTHOR), Dlotko, E3 (AUTHOR), Migliaccio-Walle, K.2 (AUTHOR), Samyshkin, Y4 (AUTHOR)
Source: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS112-S112. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 177910736
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Liu%2C+T%22">Liu, T</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Purser%2C+M%22">Purser, M</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gong%2C+C%22">Gong, C</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Elsea%2C+D%22">Elsea, D</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Niehoff%2C+N%22">Niehoff, N</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dlotko%2C+E%22">Dlotko, E</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Migliaccio-Walle%2C+K%2E%22">Migliaccio-Walle, K.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Samyshkin%2C+Y%22">Samyshkin, Y</searchLink><relatesTo>4</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Value+in+Health%22">Value in Health</searchLink>. 2024 Supplement, Vol. 27 Issue 6, pS112-S112. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=177910736
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jval.2024.03.599
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S112
    Titles:
      – TitleFull: EE300 Cost Effectiveness of Momelotinib Vs Other Treatments for Myelofibrosis from a US Payer Perspective.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Liu, T
      – PersonEntity:
          Name:
            NameFull: Purser, M
      – PersonEntity:
          Name:
            NameFull: Gong, C
      – PersonEntity:
          Name:
            NameFull: Elsea, D
      – PersonEntity:
          Name:
            NameFull: Niehoff, N
      – PersonEntity:
          Name:
            NameFull: Dlotko, E
      – PersonEntity:
          Name:
            NameFull: Migliaccio-Walle, K.
      – PersonEntity:
          Name:
            NameFull: Samyshkin, Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 06
              Text: 2024 Supplement
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 10983015
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Value in Health
              Type: main
ResultId 1